SCHEMBL3157735

SCHEMBL3157735

COC(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(CN2CCN(C(=O)c3ccccc3)CC2)cc1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
MAPT P10636 3/20 0.47
GAA P10253 2/20 0.47
HPGD P15428 1/20 0.47
PRKAB2 O43741 2/20 0.47
PRKAG1 P54619 2/20 0.47
PRKAA2 P54646 2/20 0.47
PRKAA1 Q13131 2/20 0.47
PRKAG3 Q9UGI9 2/20 0.47
PRKAG2 Q9UGJ0 2/20 0.47
PRKAB1 Q9Y478 2/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
HSD17B10 Q99714 1/20 0.47
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
LMNA P02545 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3157727 1.00 ALDH1A1 (0.54) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL480994 0.93 MAPK1 (0.55) ALDH1A1MEN1KMT2AMAPTPRKAB2
SCHEMBL480996 0.93 MAPK1 (0.55) ALDH1A1MEN1KMT2AMAPTPRKAB2
SCHEMBL3143524 0.92 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL3143515 0.92 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL2569954 0.92 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL3149615 0.92 KMT2A (0.49) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL2569950 0.92 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL3149606 0.92 KMT2A (0.49) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL2122565 0.92 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 US disclosed
EP-1224170-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT Boehringer Ingelheim Pharma KG (DE) 2002-07-24 EP disclosed
WO-2001027081-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-19 WO disclosed